Purpose
to develop a recombinant adeno-associated virus (rAAV) vector that is both more robust at transducing human muscle cells in vivo, and more resilient to neutralization by pre-existing human antibodies
Grantee
Division
Global Health
Date
OCTOBER 2013
Region served
GLOBAL
Committed amount
$992,376
Grant topic
HIV
Duration (months)
28
Grantee location
Redwood City, California, United States
Related work
More about our work
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.